ENZN : Summary for ENZON PHARMACEUTIC COM USD0.01 - Yahoo Finance

U.S. Markets closed

Enzon Pharmaceuticals, Inc. (ENZN)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.24-0.00 (-1.10%)
At close: 3:15PM EDT
People also watch
QLTIALKSPDLIMYGNARQL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.25
Open0.25
Bid0.00 x
Ask0.00 x
Day's Range0.24 - 0.26
52 Week Range0.22 - 0.53
Volume39,314
Avg. Volume79,785
Market Cap10.77M
Beta0.76
PE Ratio (TTM)-8.12
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017
    Capital Cube29 days ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017

    Categories: Yahoo Finance Get free summary analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Amgen Inc., Enanta Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, XOMA Corporation, SciClone Pharmaceuticals, Inc. and Gilead ... Read more (Read more...)

  • Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals
    GuruFocus.com5 months ago

    Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals

    Activist investor continues his interest in penny stock

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
    Capital Cube5 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Amgen Inc., Merck & Co., Inc., XOMA Corporation, Bristol-Myers Squibb Company, Pfizer Inc., SciClone Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated and Gilead Sciences, ... Read more (Read more...)